Fig 1: The qRT-PCR results of 11genes. a–h. STARD5, FTCD, SCN4A, ADH4, CFHR3, CYP2C9, CCL14, and GADD45G were weakly expressed in HCC tissues. i–k. SOX11, SCIN, and SLC2A1 were upregulated in HCC tissues. N adjacent normal tissue, T tumor tissue
Fig 2: Stard5 downregulation is associated with poor prognosis of HCC. a. Six pairs of tumor and para-tumor tissues were randomly selected for western blot analysis (left panel). The relative intensity of Stard5 protein was normalized to β-actin (right panel). b, c. Representative IHC image percentage of Stard5 expression in HCC tumor (T) and para-tumor tissues (N). Scale bar, 500 μm or 125 μm. d, e Time to recurrence and overall survival of HCC patients in the high and low group were estimated using the Kaplan–Meier method. * p < 0.05
Fig 3: The correlation between Stard5 and EMT in HCC tissues. (a) Representative IHC images of Stard5, N-cadherin, Vimentin, E-cadherin and zo-1 expression in HCC patient paraffin section. Pearson’s correlation of IHC score was calculated in 15 HCC tissues
Supplier Page from Abcam for Anti-STARD5 antibody [EPR13545(B)]